Clinical Trials Directory

Trials / Conditions / T-Cell/Histiocyte-Rich Large B-Cell Lymphoma

T-Cell/Histiocyte-Rich Large B-Cell Lymphoma

7 registered clinical trials studyying T-Cell/Histiocyte-Rich Large B-Cell Lymphoma — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingEpcoritamab With Dose Adjusted Etoposide, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone and Rituximab
NCT07097363
University of WashingtonPhase 2
RecruitingPembro Plus CAR T-cell Therapy in R/R in PMBCL
NCT05934448
Jennifer Crombie, MDPhase 2
Active Not RecruitingAcalabrutinib + Liso-Cel In R/R Aggressive B-Cell Lymphomas
NCT05583149
Patrick C. Johnson, MDPhase 2
SuspendedTesting CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diag
NCT04799275
National Cancer Institute (NCI)Phase 2 / Phase 3
RecruitingPolatuzumab Vedotin and Combination Chemotherapy With or Without Glofitamab for the Treatment of Untreated Agg
NCT04231877
University of WashingtonPhase 1
CompletedCombination Chemotherapy and TAK-659 as Front-Line Treatment in Treating Patients With High-Risk Diffuse Large
NCT03742258
Northwestern UniversityPhase 1
SuspendedNivolumab and Combination Chemotherapy in Treating Participants With Diffuse Large B-Cell Lymphoma
NCT03704714
Northwestern UniversityPhase 1 / Phase 2